Wednesday, March 19, 2025 12:47:34 PM
I think I answered this question in one of my posts.
The Company doesn't have the same opinion on the topic of PRs as some on this board does...including me as early as yesterday.
I will give them the benefit of the doubt (more so now) that they have a better view of all things, than we do. Including NICE, MTD and direction after decision, MMs and manipulation, and progress after Approval.
Approval starts the ball rolling IMO. I'm more optimistic about approval and focus and future direction as a result of my conversation.
Disclosure: This was my first conversation with the company (Les) and I'm not very good at the technical/scientific subjects of DCVax. So I didn't ask any questions about the science. IMO...these questions have already been answered. Or nobody would still be here. But I did ask a lot of questions...and follow up questions...about things that I've included in this post.
The Company doesn't have the same opinion on the topic of PRs as some on this board does...including me as early as yesterday.
I will give them the benefit of the doubt (more so now) that they have a better view of all things, than we do. Including NICE, MTD and direction after decision, MMs and manipulation, and progress after Approval.
Approval starts the ball rolling IMO. I'm more optimistic about approval and focus and future direction as a result of my conversation.
Disclosure: This was my first conversation with the company (Les) and I'm not very good at the technical/scientific subjects of DCVax. So I didn't ask any questions about the science. IMO...these questions have already been answered. Or nobody would still be here. But I did ask a lot of questions...and follow up questions...about things that I've included in this post.
Bullish
"What one man can do...another man can do" - The Edge -
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
